Recruiting PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT06108063

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

Sponsor: Steadman Philippon Research Institute

Interventions Losartan Placebo - Losartan

Updated 5 times since 2023 Last updated: Mar 7, 2024 Started: Mar 6, 2024 Primary completion: Jun 30, 2027 Completion: Jun 30, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Knee Arthroplasty, Total and is currently actively recruiting participants. Steadman Philippon Research Institute leads this study, which shows 5 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Recruiting PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Apr 2024 — Jul 2024 [monthly]

Recruiting PHASE1_PHASE2
Dec 2023 — Apr 2024 [monthly]

Recruiting PHASE1_PHASE2

Status: Not Yet Recruiting → Recruiting
Nov 2023 — Dec 2023 [monthly]

Not Yet Recruiting PHASE1_PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Steadman Philippon Research Institute

Data source: Steadman Philippon Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vail, United States